{"id":"W2912026765","doi":"10.1016/j.msard.2019.01.044","title":"Ocrelizumab infusion experience in patients with relapsing and primary progressive multiple sclerosis: Results from the phase 3 randomized OPERA I, OPERA II, and ORATORIO studies","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia","funders":"Schweizerische Multiple Sklerose Gesellschaft; European Commission; Universitätsspital Basel; Bayer HealthCare; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Novartis Foundation; F. Hoffmann-La Roche","keywords":"Medicine; Ocrelizumab; Oratorio; Multiple sclerosis; Opera; Internal medicine; Literature; Psychiatry; Musical; Art","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002757081,0.0008302251,0.00233144,0.0002545277,0.0004724739,0.0009644533,0.0004948836,0.000905318,0.001180694],"category_scores_gemma":[0.002280008,0.0003658091,0.002081474,0.0004286238,0.0008973356,0.001063747,0.000460219,0.002266256,0.0002323875],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005839176,"about_ca_system_score_gemma":0.001109624,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008394255,"about_ca_topic_score_gemma":0.001410054,"domain_scores_codex":[0.9987828,0.0006626487,0.00009569083,0.0001557947,0.0001051874,0.0001978569],"domain_scores_gemma":[0.9978513,0.0006538823,0.0006274619,0.00015831,0.0001086022,0.0006004627],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9161382,0.01068622,0.01675208,0.0006407346,0.003164688,0.0001060376,0.0002510861,0.0004216108,0.003937656,0.0001428583,0.0008324938,0.04692648],"study_design_scores_gemma":[0.735854,0.2000918,0.05594615,0.0001007716,0.004175742,0.000219454,0.000198568,0.0003963591,0.0009230335,0.0002591223,0.001787673,0.00004736553],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950148,0.003575491,0.0001159062,0.0001927836,0.00006558294,0.0002036958,0.0002345102,0.00001017558,0.0005870634],"genre_scores_gemma":[0.9962733,0.001571189,0.0003379215,0.0004949733,0.0001725873,0.0002642071,0.0005265482,0.000006161833,0.0003531012],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002757081,"threshold_uncertainty_score":0.01458102,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0340385116582444,"score_gpt":0.2778177616240176,"score_spread":0.2437792499657732,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}